Showing results (321-330 of 355) with videos related to
Sort By:
Pageof 36
Public Health|August 19, 2021
National population prevalence of antibodies to SARS-CoV-2 in Scotland during the first and second waves of the COVID-19 pandemicN E Palmateer, E Dickson, E Furrie, et al.Human Gene Therapy|May 24, 2006
Correction of feline lipoprotein lipase deficiency with adeno-associated virus serotype 1-mediated gene transfer of the lipoprotein lipase S447X beneficial mutationColin J D Ross, Jaap Twisk, Andrew C Bakker, et al.Public Health|September 13, 2021
National population prevalence of antibodies to SARS-CoV-2 among pregnant women in Scotland during the second wave of the COVID-19 pandemic: a prospective national serosurveyA McAuley, P Gousias, T Hasan, et al.Nature Genetics|November 10, 2009
Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapyColin J D Ross, Hagit Katzov-Eckert, Marie-Pierre Dubé, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2025
Development and Validation of a Novel Prediction Model for Hearing Loss From Cisplatin ChemotherapyJoshua Millstein, Shahrad R Rassekh, Austin L Brown, et al.Gene Therapy|March 27, 2025
Optimization of adeno-associated viral (AAV) gene therapies vectors for balancing efficacy, longevity and safety for clinical applicationNeel Mehta, Rénald Gilbert, Parminder S Chahal, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|June 12, 2026
Liposomal lipid nanoparticles containing dihydrosphingomyelin exhibit improved stability and extended hepatic and extrahepatic transfectionSuiyang Liao, Kevin Fox, Alexandra Birkenshaw, et al.Canadian Journal of Kidney Health and Disease|March 9, 2017
Design and Methods of the Pan-Canadian Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Nephrotoxicity Study: A Prospective Observational Cohort StudyKelly R McMahon, Shahrad Rod Rassekh, Kirk R Schultz, et al.Pediatric Blood & Cancer|February 27, 2013
Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in childrenH Visscher, C J D Ross, S R Rassekh, et al.Journal of Viral Hepatitis|October 8, 2014
HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impactN K Martin, G R Foster, J Vilar, et al.Pageof 36